Printer Friendly

Brook Venture Partners Closes $100 Million Fund.

Investors Include State of Pennsylvania, Merrill Lynch, Bank North, State of Vermont, Finance Authority of Maine and Brooke Private Equity

BOSTON -- Brook Venture Partners ("Brook"), a provider of capital to expansion stage companies, announces today that it has held the final closing on its second fund, Brook Venture Fund II, LP ("Brook II"). Investors include the State of Pennsylvania, State of Vermont, Finance Authority of Maine, Bank North, Merrill Lynch, Brooke Private Equity, Green Stamps America, and other institutional and individual investors. The $100 million fund will make investments in select IT and Medical Technology companies throughout the Northeast.

"Our investors selected Brook because of our team's top quartile performance and the fact that we're one of the few funds focusing on an underserved niche," said Ned Williams, partner with Brook. "Most funds have left the $2-5 million investment segment, whereas Brook has demonstrated this niche to be a vibrant market for finding good companies at reasonable valuations."

Brook II is a licensee of the Small Business Administration's highly selective SBIC program. In 2005, when the Fund received its license, the SBA issued a total of only eleven such licenses to funds across the country.

"We demonstrated our investment capabilities to the SBA, as well as our ability to assist companies during the most rapid stage of their growth. We are very pleased to have received the license and be part of this program," said Walter Beinecke, partner with Brook.

Investment Focus & Strategy

Brook invests primarily in expansion stage companies in the Information Technology and Medical Technology sectors. Investments made by Brook II to date include Repromedix Corp., Wandrian, Inc., HistoRx, Inc., and Anodyne Health Partners, Inc.

"IT and medical technology are two key high growth/high innovation areas experiencing a need for capital and the kind of advice and counsel a venture investor can offer," said Fred Morris, partner with Brook.

"Young companies increasingly need expansion stage capital and welcome Brook's investment approach," said Andrew Clapp, partner with Brook. "Brook fills the gap between the smaller, individual investors who top out at around $1 million, and larger private equity players who typically invest far more than $5 million per deal. We provide that critical $2-5 million piece that can accelerate a young company's growth."

About Brook Venture Partners

Headquartered just outside of Boston, Brook Venture Partner's investment team includes four senior partners: Andrew Clapp, Fred Morris, Ned Williams, and Walter Beinecke, and a seasoned support team. Having invested in dozens of companies, Brook provides capital, counsel and a team-building approach to investing that builds young companies to a 'mid-market' size. For additional information, go to www.brookventure.com or call 781-295-4000.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 23, 2007
Words:442
Previous Article:Viewers will Pick MVP of Super Bowl Commercials.
Next Article:The Vitamin Shoppe Voluntarily Removes "Especially for Women" Multivitamin, Stands Behind Quality and Safety of Its Products.
Topics:


Related Articles
Venture capital: 'the market is in its adolescence.' (Ann Winblad of Hummer Winblad Venture Partners, a capital venture firm for software companies,...
SL Green in joint venture to buy 1250 Broadway.
Sterling American Property closes 4th fund.
AMGEN TO INVEST IN OTHER DRUG RESEARCH FIRMS.
State trots out new investment fund.
Department of Energy moving on security initiatives.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters